Sorafenib plus tislelizumab as maintenance therapy for patients with advanced hepatocellular carcinoma treated with transarterial chemoembolization: A phase II study.

被引：0
|
作者：
Cai, Mingyue [1 ]
Hong, Xiaoyang [1 ]
Huang, Wensou [1 ]
Guo, Yongjian [1 ]
Shi, Wenbo [1 ]
Liang, Licong [1 ]
Zhou, Jingwen [1 ]
Lin, Liteng [1 ]
Chen, Ye [1 ]
Zhu, Kangshun [1 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
574
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [21] Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study
    Zhao, Yushan
    Wen, Shuwei
    Xue, Yaoqing
    Dang, Zhijun
    Nan, Zhiyu
    Wang, Dong
    Li, Xiao
    Feng, Duiping
    Chen, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib
    Lee, Dae-Won
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Tae-Yong
    Han, Sae-Won
    Oh, Youn
    Im, Seock-Ah
    Kim, Tae-You
    Lee, Youngeun
    Kim, Haeryoung
    Lee, Kyung-Hun
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 713 - 718
  • [23] Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
    Abou-Alfa, Ghassan K.
    Schwartz, Lawrence
    Ricci, Sergio
    Amadori, Dino
    Santoro, Armando
    Figer, Arie
    De Greve, Jacques
    Douillard, Jean-Yves
    Lathia, Chetan
    Schwartz, Brian
    Taylor, Ian
    Moscovici, Marius
    Saltz, Leonard B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) : 4293 - 4300
  • [24] The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma
    Lee, Shou Wu
    Lee, Teng Yu
    Peng, Yen Chun
    Yang, Sheng Shun
    Yeh, Hong Zen
    Chang, Chi Sen
    JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (05) : 287 - 292
  • [25] Advanced-Stage Hepatocellular Carcinoma: Transarterial Chemoembolization versus Sorafenib
    Pinter, Matthias
    Hucke, Florian
    Graziadei, Ivo
    Vogel, Wolfgang
    Maieron, Andreas
    Koenigsberg, Robert
    Stauber, Rudolf
    Gruenberger, Birgit
    Mueller, Christian
    Koelblinger, Claus
    Peck-Radosavljevic, Markus
    Sieghart, Wolfgang
    RADIOLOGY, 2012, 263 (02) : 590 - 599
  • [26] The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
    Yingqiang Zhang
    Hongfei Miao
    Wenlin Xie
    Suxiang Jiang
    Ze Song
    Guihua Huang
    Wenzhe Fan
    Yu Wang
    Jiaping Li
    Yong Chen
    European Radiology, 2021, 31 : 232 - 243
  • [27] The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
    Zhang, Yingqiang
    Miao, Hongfei
    Xie, Wenlin
    Jiang, Suxiang
    Song, Ze
    Huang, Guihua
    Fan, Wenzhe
    Wang, Yu
    Li, Jiaping
    Chen, Yong
    EUROPEAN RADIOLOGY, 2021, 31 (01) : 232 - 243
  • [28] Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews
    Yan, Jingxin
    Wen, Yonghao
    Deng, Manjun
    Ye, Bin
    Liu, Xinlian
    Zhang, Lushun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1723 - 1733
  • [29] Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma
    Sinakos, Emmanouil
    Dedes, Ioannis
    Papalavrentios, Lavrentis
    Drevelegas, Antonios
    Akriviadis, Evangelos
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (04) : 511 - 512
  • [30] Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study
    Dufour, Jean-Francois
    Hoppe, Hanno
    Heim, Markus H.
    Helbling, Beat
    Maurhofer, Olivier
    Szucs-Farkas, Zsolt
    Kickuth, Ralph
    Borner, Markus
    Candinas, Daniel
    Saar, Bettina
    ONCOLOGIST, 2010, 15 (11): : 1198 - 1204
12345